Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change
25/08/26	€1.090	-6.84%
21/08/26	€1.170	-6.77%
20/08/26	€1.255	-6.34%
19/08/26	€1.340	+19.64%
18/08/26	€1.120	-22.49%

Real-time Boerse Muenchen

More quotes

Market Closed - Boerse Muenchen 00:43:38 25/08/2026 +04			5-day change	1st Jan Change
1.090 ^EUR	-6.84%		-2.50%	+36.36%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.36M 2.69M 2.46M 4.64M 321M 4.69M 31.84M 12.38M 161M 12.6M 12.33M 534M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.62M 3.7M 3.38M 6.39M 442M 6.45M 43.8M 17.03M 222M 17.34M 16.96M 735M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	99.21%	Yield 2023 *	-	Yield 2024	-

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
06/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Stock Boerse Muenchen

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Course Extremes

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Quotes

08-19	Bourse : série de résultats en Europe, flambée d'Unitree et puces Nvidia en Chine
08-18	Klarsen nomme un nouveau DG pour sa filiale ITL Datamarketing
08-18	Klarsen : ALKLA – Olivier Cornelis nommé Directeur Général d’ITL – 18 Août 2026
08-18	KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
08-03	Klarsen : Information réglementée – 2026

1 week	-2.50%
Current month	+78.35%
3 months	+94.35%
6 months	+10.90%
Current year	+36.36%

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	23/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	-6.84%	-2.50%	+29.42%	-69.29%	4.49M
IBM	-1.97%	-1.40%	-4.56%	+61.10%	222B
SNOWFLAKE INC.	-3.00%	-1.87%	+64.01%	+107.31%	115B
ACCENTURE PLC	+0.67%	+5.45%	-28.04%	-40.85%	113B
TATA CONSULTANCY SERVICES LTD.	-0.78%	-3.26%	-25.21%	-32.79%	87.05B
RELX PLC	+1.53%	+4.99%	-26.00%	+6.08%	62.19B
INFOSYS LIMITED	+0.80%	-3.35%	-24.03%	-19.74%	47.45B
FUJITSU LIMITED	+1.48%	-3.67%	+2.98%	+105.96%	39.79B
NEC CORPORATION	+1.10%	-8.92%	+1.53%	+215.06%	38.85B
HCL TECHNOLOGIES LIMITED	+1.50%	-2.79%	-9.84%	+11.80%	36.84B
Average	+0.35%	-1.66%	-1.98%	+34.46%	84.77B
Weighted average by Cap.	-0.32%	-0.11%	-2.55%	+40.51%

	2023	2024
Net sales	5.03M 5.86M 4.7M 4.3M 8.11M 562M 8.2M 55.64M 21.63M 282M 22.02M 21.54M 933M	6.31M 7.36M 5.9M 5.4M 10.19M 705M 10.29M 69.86M 27.17M 354M 27.65M 27.05M 1.17B
Net income	2.75M 3.21M 2.57M 2.35M 4.44M 307M 4.49M 30.45M 11.84M 154M 12.05M 11.79M 511M	-47.76K -55.74K -44.68K -40.85K -77.09K -5.34M -77.91K -529K -206K -2.68M -209K -205K -8.87M
Net Debt	-634K -740K -594K -543K -1.02M -70.89M -1.03M -7.02M -2.73M -35.6M -2.78M -2.72M -118M	1.08M 1.26M 1.01M 924K 1.74M 121M 1.76M 11.96M 4.65M 60.63M 4.74M 4.63M 201M

1 week	1.09	1.44
3 years	0	3.99
5 years	0	3.99